- Home
- SNTI vs SIF Comparison
SNTI vs SIF Comparison
Compare SNTI & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- SIF
- Stock Information
- Founded
- SNTI 2016
- SIF 1913
- Country
- SNTI United States
- SIF United States
- Employees
- SNTI N/A
- SIF N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- SIF Office Equipment/Supplies/Services
- Sector
- SNTI Health Care
- SIF Industrials
- Exchange
- SNTI Nasdaq
- SIF Nasdaq
- Market Cap
- SNTI 21.3M
- SIF 22.6M
- IPO Year
- SNTI N/A
- SIF N/A
- Fundamental
- Price
- SNTI $3.96
- SIF $3.25
- Analyst Decision
- SNTI Strong Buy
- SIF
- Analyst Count
- SNTI 1
- SIF 0
- Target Price
- SNTI $12.00
- SIF N/A
- AVG Volume (30 Days)
- SNTI 30.3K
- SIF 3.3K
- Earning Date
- SNTI 03-20-2025
- SIF 02-14-2025
- Dividend Yield
- SNTI N/A
- SIF N/A
- EPS Growth
- SNTI N/A
- SIF N/A
- EPS
- SNTI N/A
- SIF N/A
- Revenue
- SNTI N/A
- SIF $85,042,000.00
- Revenue This Year
- SNTI $11.52
- SIF N/A
- Revenue Next Year
- SNTI $78.57
- SIF N/A
- P/E Ratio
- SNTI N/A
- SIF N/A
- Revenue Growth
- SNTI N/A
- SIF 41.17
- 52 Week Low
- SNTI $1.52
- SIF $2.90
- 52 Week High
- SNTI $16.94
- SIF $5.96
- Technical
- Relative Strength Index (RSI)
- SNTI 45.36
- SIF 34.69
- Support Level
- SNTI $3.92
- SIF $3.28
- Resistance Level
- SNTI $4.50
- SIF $3.89
- Average True Range (ATR)
- SNTI 0.26
- SIF 0.14
- MACD
- SNTI -0.03
- SIF -0.06
- Stochastic Oscillator
- SNTI 20.59
- SIF 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.